Hepatitis B cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) Created page with "{{Hepatitis B}} {{CMG}} {{EJ}} == References == {{Reflist|2}} B Category:Viruses Category:Infectious disease [[Category:Gastroenterology]..." |
m Bot: Removing from Primary care |
||
(11 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Hepatitis B}} | {{Hepatitis B}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{JS}} | ||
{{ | ==Overview== | ||
Given the risk of complications (e.g., [[cirrhosis]] or [[hepatocellular carcinoma]]) in infants and young children who are infected with the [[HBV]], as well as the benefits of [[vaccination]] and postexposure [[prophylaxis]], the prevention and treatment of hepatitis B are considered cost-effective.<ref name=WHO>{{cite web | title = Hepatitis B | url = http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf }}</ref> | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:FinalQCRequired]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hepatology]] |
Latest revision as of 22:04, 29 July 2020
Hepatitis B |
Diagnosis |
Treatment |
Case Studies |
Hepatitis B cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Hepatitis B cost-effectiveness of therapy |
Risk calculators and risk factors for Hepatitis B cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Given the risk of complications (e.g., cirrhosis or hepatocellular carcinoma) in infants and young children who are infected with the HBV, as well as the benefits of vaccination and postexposure prophylaxis, the prevention and treatment of hepatitis B are considered cost-effective.[1]
References
- ↑ "Hepatitis B" (PDF).